• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为强效可溶性环氧化物水解酶抑制剂的生物活性酯衍生物。

Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.

机构信息

Department of Entomology and UC Davis Comprehensive Cancer Center, University of California, One Shields Avenue, Davis, CA 95616, USA.

出版信息

Bioorg Med Chem Lett. 2012 Sep 15;22(18):5889-92. doi: 10.1016/j.bmcl.2012.07.074. Epub 2012 Aug 2.

DOI:10.1016/j.bmcl.2012.07.074
PMID:22901393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3432147/
Abstract

Substituted ureas with a carboxylic acid ester as a secondary pharmacophore are potent soluble epoxide hydrolase (sEH) inhibitors. Although the ester substituent imparts better physical properties, such compounds are quickly metabolized to the corresponding less potent acids. Toward producing biologically active ester compounds, a series of esters were prepared and evaluated for potency on the human enzyme, stability in human liver microsomes, and physical properties. Modifications around the ester function enhanced in vitro metabolic stability of the ester inhibitors up to 32-fold without a decrease in inhibition potency. Further, several compounds had improved physical properties.

摘要

用羧酸酯替代脲作为第二药效团的取代基是强效的可溶性环氧化物水解酶(sEH)抑制剂。尽管酯取代基赋予了更好的物理性质,但这些化合物很快会代谢为效力较低的相应酸。为了产生具有生物活性的酯化合物,我们合成了一系列酯类化合物,并评估了它们对人源酶的效力、在人肝微粒体中的稳定性以及物理性质。酯功能的修饰使酯抑制剂的体外代谢稳定性提高了 32 倍,而抑制效力没有降低。此外,一些化合物的物理性质得到了改善。

相似文献

1
Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.作为强效可溶性环氧化物水解酶抑制剂的生物活性酯衍生物。
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5889-92. doi: 10.1016/j.bmcl.2012.07.074. Epub 2012 Aug 2.
2
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.探究可溶性环氧化物水解酶抑制剂疏水区部分的大小。
Bioorg Med Chem. 2019 Oct 15;27(20):115078. doi: 10.1016/j.bmc.2019.115078. Epub 2019 Aug 26.
3
Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.发现邻苯二甲酰亚胺衍生物作为新型可溶性环氧化物水解酶抑制剂。
Arch Pharm (Weinheim). 2020 Aug;353(8):e2000052. doi: 10.1002/ardp.202000052. Epub 2020 Jun 2.
4
Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.具有改善物理性质和效力的可溶性环氧化物水解酶抑制剂的制备和评价,用于治疗糖尿病性神经痛。
Bioorg Med Chem. 2020 Nov 15;28(22):115735. doi: 10.1016/j.bmc.2020.115735. Epub 2020 Aug 31.
5
Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.咪唑烷-2,4,5-二酮和嘧啶-2,4,6-三酮——具有增强水溶性的可溶性环氧化物水解酶抑制剂的新型主要药效基团。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126908. doi: 10.1016/j.bmcl.2019.126908. Epub 2019 Dec 18.
6
Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.氟维司群和亚砜对可溶性环氧化物水解酶的抑制作用。
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3818-21. doi: 10.1016/j.bmcl.2013.04.083. Epub 2013 May 6.
7
Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.作为人可溶性环氧化物水解酶抑制剂的酰胺 - 膦酸酯衍生物的构效关系
Bioorg Med Chem. 2015 Nov 15;23(22):7199-210. doi: 10.1016/j.bmc.2015.10.016. Epub 2015 Oct 22.
8
Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.取代氧代草酰胺作为人可溶性环氧化物水解酶抑制剂的构效关系
Bioorg Med Chem. 2014 Feb 1;22(3):1163-75. doi: 10.1016/j.bmc.2013.12.027. Epub 2014 Jan 3.
9
Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.设计和合成取代烟酰胺作为可溶性环氧化物水解酶抑制剂。
Bioorg Med Chem Lett. 2009 Oct 15;19(20):5864-8. doi: 10.1016/j.bmcl.2009.08.074. Epub 2009 Aug 26.
10
Identification of potent inhibitors of the chicken soluble epoxide hydrolase.鸡可溶性环氧化物水解酶强效抑制剂的鉴定
Bioorg Med Chem Lett. 2015 Jan 15;25(2):276-9. doi: 10.1016/j.bmcl.2014.11.053. Epub 2014 Nov 26.

引用本文的文献

1
Intensification of Double Kinetic Resolution of Chiral Amines and Alcohols via Chemoselective Formation of a Carbonate-Enzyme Intermediate.通过选择性形成碳酸酯-酶中间物来强化手性胺和醇的双动力学拆分。
Molecules. 2022 Jul 6;27(14):4346. doi: 10.3390/molecules27144346.
2
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.探究可溶性环氧化物水解酶抑制剂疏水区部分的大小。
Bioorg Med Chem. 2019 Oct 15;27(20):115078. doi: 10.1016/j.bmc.2019.115078. Epub 2019 Aug 26.
3
Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit.可溶性环氧化物水解酶抑制剂UC1728对兔脂多糖诱导性葡萄膜炎的作用
J Ocul Biol. 2016 Jan;4(1). doi: 10.13188/2334-2838.1000024. Epub 2016 Jan 12.
4
Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.通过分子对接和MM-GBSA研究1,3,4-恶二唑衍生物作为基于酰胺的可溶性环氧化物水解酶(sEH)抑制剂的结合模式。
Eur Biophys J. 2017 Jul;46(5):445-459. doi: 10.1007/s00249-016-1188-0. Epub 2016 Dec 7.
5
Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.铜绿假单胞菌环氧化物水解酶毒力因子强效和选择性抑制剂的合理设计
J Med Chem. 2016 May 26;59(10):4790-9. doi: 10.1021/acs.jmedchem.6b00173. Epub 2016 May 4.
6
Design, synthesis and biological evaluation of 4-benzamidobenzoic Acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors.新型可溶性环氧化物水解酶抑制剂4-苯甲酰胺基苯甲酸酰肼衍生物的设计、合成及生物学评价
Iran J Pharm Res. 2014 Winter;13(Suppl):51-9.
7
Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.取代氧代草酰胺作为人可溶性环氧化物水解酶抑制剂的构效关系
Bioorg Med Chem. 2014 Feb 1;22(3):1163-75. doi: 10.1016/j.bmc.2013.12.027. Epub 2014 Jan 3.

本文引用的文献

1
Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors.靶向可溶性环氧化物水解酶治疗炎症和疼痛——药理学及抑制剂概述
Inflamm Allergy Drug Targets. 2012 Apr;11(2):143-58. doi: 10.2174/187152812800392823.
2
Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.可溶性环氧化物水解酶抑制剂的发现:一个具有多种潜在治疗适应症的靶点。
J Med Chem. 2012 Mar 8;55(5):1789-808. doi: 10.1021/jm201468j. Epub 2012 Jan 17.
3
Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.可溶性环氧化物水解酶抑制剂介导的镇痛作用依赖于 cAMP。
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5093-7. doi: 10.1073/pnas.1101073108. Epub 2011 Mar 7.
4
Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase.作为可溶性环氧化物水解酶抑制剂的环烷基酰胺衍生物的构效关系。
J Med Chem. 2011 Mar 24;54(6):1752-61. doi: 10.1021/jm101431v. Epub 2011 Feb 21.
5
Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.不对称 N,N'-二芳基脲类可溶性环氧化物水解酶抑制剂的次要和 tertiary 药效团的探索。
Bioorg Med Chem Lett. 2010 May 1;20(9):2740-4. doi: 10.1016/j.bmcl.2010.03.074. Epub 2010 Mar 19.
6
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.发现螺环仲胺衍生的叔脲作为高效、选择性和生物可利用的可溶性环氧化物水解酶抑制剂。
Bioorg Med Chem Lett. 2009 Jul 1;19(13):3398-404. doi: 10.1016/j.bmcl.2009.05.036. Epub 2009 May 18.
7
Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.具有高代谢稳定性和化学稳定性的基于水杨酸酯-尿素的可溶性环氧化物水解酶抑制剂。
Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. doi: 10.1016/j.bmcl.2009.01.069. Epub 2009 Jan 27.
8
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.选择性环氧二十碳三烯酸(EET)拮抗剂14,15-环氧-二十碳-5Z,8Z,11Z,14Z-四烯酸乙酯(14,15-EEZE)对犬心脏中外源性或内源性EETs产生的心脏保护作用的影响。
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2838-44. doi: 10.1152/ajpheart.00186.2008. Epub 2008 Apr 25.
9
1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.用醚基官能化的1,3 - 二取代脲是具有改善药代动力学性质的可溶性环氧化物水解酶的有效抑制剂。
J Med Chem. 2007 Oct 18;50(21):5217-26. doi: 10.1021/jm070705c. Epub 2007 Sep 26.
10
Orally bioavailable potent soluble epoxide hydrolase inhibitors.口服生物可利用的强效可溶性环氧化物水解酶抑制剂。
J Med Chem. 2007 Aug 9;50(16):3825-40. doi: 10.1021/jm070270t. Epub 2007 Jul 6.